Finolex Industries Stock Gains Most Since May 2013 After Q3 Results
Shares of Finolex Industries Ltd. gained the most in more than seven years after the maker of PVC pipes and fittings beat analysts' estimates in the quarter ended December.
The company's net profit more than doubled over the year earlier to Rs 259.4 crore in the October-December period, according to an exchange filing. That compares with the Rs 138.8-crore consensus estimate of analysts tracked by Bloomberg.
Its revenue rose 53% to Rs 1,066.9 crore, compared with the predicted Rs 895.5 crore. Higher volumes in PVR pipes and fittings, and the PVC resin segment aided the top line.
- Volumes for PVC pipes and fittings business rose 4.7% year-on-year to 55,299 MT
- PVR resin volumes increased 14.5% to 67,741 MT.
“During the quarter, PVC prices touched historic highs on account of numerous global supply-side constraints,” Finolex said in its investor presentation.
- Operating profit, or earnings before interest, tax, depreciation and amortisation, more than doubled over the year earlier to Rs 346.6 crore, against Rs 195.6-crore estimate.
- Ebitda margin expanded to 32.5% from 19%.
The company also announced a split of one equity share of Rs 10 each into two equity shares of Rs 5 each. It expects to complete the process of the stock split over the next three to four months.
Shares of Finolex Industries gained as much as 16.2% as of 10:40 a.m.—the biggest single-day rally since May 2013—to Rs 689 apiece. That is also the highest level since February 2018.
Of the 18 analysts tracking the company, 17 recommend a ‘buy', while one suggests a ‘hold'. The average of Bloomberg consensus 12-month price target implies an upside of 15.3%.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.